SEVERE AND PROLONGED HYPOGLYCEMIC SHOCK DURING SULFONYLUREA TREATMENT.
D000092:Acetohexamide; D002747:Chlorpropamide; D003920:Diabetes Mellitus; D003925:Diabetic Angiopathies; D003926:Diabetic Coma; D005853:Geriatrics; D007003:Hypoglycemia; D007004:Hypoglycemic Agents; D002537:Intracranial Arteriosclerosis; D007674:Kidney Diseases; D010336:Pathology; D012769:Shock; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D014116:Toxicology
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D000092:Acetohexamide; C100077:metahexamide; D002747:Chlorpropamide
ACETOHEXAMIDE; ANTIDIABETICS; CEREBRAL ARTERIOSCLEROSIS; CHLORPROPAMIDE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC COMA; GERIATRICS; HYPOGLYCEMIA; KIDNEY DISEASES; METAHEXAMIDE; PATHOLOGY; SHOCK; TOLBUTAMIDE; TOXICOLOGIC REPORT